Hyperbilirubinemia  ||| S:0 E:19 ||| NNP
and  ||| S:19 E:23 ||| CC
management  ||| S:23 E:34 ||| NN
of  ||| S:34 E:37 ||| IN
breastfeeding  ||| S:37 E:51 ||| JJ
Hyperbilirubinemia  ||| S:51 E:70 ||| NNP
and  ||| S:70 E:74 ||| CC
jaundice  ||| S:74 E:83 ||| NNS
are  ||| S:83 E:87 ||| VBP
natural ||| S:87 E:94 ||| JJ
,  ||| S:94 E:96 ||| ,
physiological  ||| S:96 E:110 ||| JJ
phenomena  ||| S:110 E:120 ||| NNS
which  ||| S:120 E:126 ||| WDT
are  ||| S:126 E:130 ||| VBP
only  ||| S:130 E:135 ||| RB
to  ||| S:135 E:138 ||| TO
be  ||| S:138 E:141 ||| VB
expected  ||| S:141 E:150 ||| VBN
in  ||| S:150 E:153 ||| IN
the  ||| S:153 E:157 ||| DT
neonatal  ||| S:157 E:166 ||| JJ
period ||| S:166 E:172 ||| NN
,  ||| S:172 E:174 ||| ,
within  ||| S:174 E:181 ||| IN
certain  ||| S:181 E:189 ||| JJ
limits ||| S:189 E:195 ||| NNS
.  ||| S:195 E:197 ||| .
The  ||| S:197 E:201 ||| DT
highest  ||| S:201 E:209 ||| JJS
percentage  ||| S:209 E:220 ||| NN
of  ||| S:220 E:223 ||| IN
jaundice  ||| S:223 E:232 ||| NN
in  ||| S:232 E:235 ||| IN
breastfed  ||| S:235 E:245 ||| JJ
newborns  ||| S:245 E:254 ||| NNS
should  ||| S:254 E:261 ||| MD
be  ||| S:261 E:264 ||| VB
evaluated  ||| S:264 E:274 ||| VBN
in  ||| S:274 E:277 ||| IN
connection  ||| S:277 E:288 ||| NN
with  ||| S:288 E:293 ||| IN
inadequate  ||| S:293 E:304 ||| JJ
management  ||| S:304 E:315 ||| NN
of  ||| S:315 E:318 ||| IN
breastfeeding  ||| S:318 E:332 ||| VBG
rather  ||| S:332 E:339 ||| RB
than  ||| S:339 E:344 ||| IN
a  ||| S:344 E:346 ||| DT
direct  ||| S:346 E:353 ||| JJ
effect  ||| S:353 E:360 ||| NN
of  ||| S:360 E:363 ||| IN
breast  ||| S:363 E:370 ||| JJ
milk ||| S:370 E:374 ||| NN
.  ||| S:374 E:376 ||| .
Breastfeeding  ||| S:376 E:390 ||| NNP
is  ||| S:390 E:393 ||| VBZ
also  ||| S:393 E:398 ||| RB
linked  ||| S:398 E:405 ||| VBN
to  ||| S:405 E:408 ||| TO
visible  ||| S:408 E:416 ||| JJ
jaundice  ||| S:416 E:425 ||| JJ
persisting  ||| S:425 E:436 ||| NN
beyond  ||| S:436 E:443 ||| IN
the  ||| S:443 E:447 ||| DT
first  ||| S:447 E:453 ||| JJ
two  ||| S:453 E:457 ||| CD
weeks  ||| S:457 E:463 ||| NNS
of  ||| S:463 E:466 ||| IN
life  ||| S:466 E:471 ||| NN
( ||| S:471 E:472 ||| -LRB-
breast  ||| S:472 E:480 ||| FW
milk  ||| S:480 E:485 ||| FW
jaundice ||| S:485 E:494 ||| FW
) ||| S:494 E:495 ||| -RRB-
,  ||| S:495 E:497 ||| ,
but  ||| S:497 E:501 ||| CC
the  ||| S:501 E:505 ||| DT
appearance  ||| S:505 E:516 ||| NN
of  ||| S:516 E:519 ||| IN
skin  ||| S:519 E:524 ||| NN
jaundice  ||| S:524 E:533 ||| NN
is  ||| S:533 E:536 ||| VBZ
not  ||| S:536 E:540 ||| RB
a  ||| S:540 E:542 ||| DT
reason  ||| S:542 E:549 ||| NN
for  ||| S:549 E:553 ||| IN
interrupting  ||| S:553 E:566 ||| VBG
breastfeeding  ||| S:566 E:580 ||| NNS
which  ||| S:580 E:586 ||| WDT
can  ||| S:586 E:590 ||| MD
and  ||| S:590 E:594 ||| CC
should  ||| S:594 E:601 ||| MD
continue  ||| S:601 E:610 ||| VB
without  ||| S:610 E:618 ||| IN
any  ||| S:618 E:622 ||| DT
interruption  ||| S:622 E:635 ||| NN
in  ||| S:635 E:638 ||| IN
most  ||| S:638 E:643 ||| JJS
cases ||| S:643 E:648 ||| NNS
.  ||| S:648 E:650 ||| .
There  ||| S:650 E:656 ||| EX
have  ||| S:656 E:661 ||| VBP
been  ||| S:661 E:666 ||| VBN
numerous  ||| S:666 E:675 ||| JJ
contributions  ||| S:675 E:689 ||| NNS
to  ||| S:689 E:692 ||| TO
the  ||| S:692 E:696 ||| DT
literature  ||| S:696 E:707 ||| NN
which  ||| S:707 E:713 ||| WDT
have  ||| S:713 E:718 ||| VBP
rescaled  ||| S:718 E:727 ||| VBG
the  ||| S:727 E:731 ||| DT
direct  ||| S:731 E:738 ||| JJ
role  ||| S:738 E:743 ||| NN
of  ||| S:743 E:746 ||| IN
breast  ||| S:746 E:753 ||| JJ
milk  ||| S:753 E:758 ||| NN
both  ||| S:758 E:763 ||| CC
in  ||| S:763 E:766 ||| IN
early  ||| S:766 E:772 ||| JJ
jaundice  ||| S:772 E:781 ||| NN
and  ||| S:781 E:785 ||| CC
in  ||| S:785 E:788 ||| IN
the  ||| S:788 E:792 ||| DT
more  ||| S:792 E:797 ||| RBR
severe  ||| S:797 E:804 ||| JJ
cases  ||| S:804 E:810 ||| NNS
of  ||| S:810 E:813 ||| IN
late  ||| S:813 E:818 ||| JJ
jaundice ||| S:818 E:826 ||| NN
.  ||| S:826 E:828 ||| .
The  ||| S:828 E:832 ||| DT
reviewed  ||| S:832 E:841 ||| JJ
guidelines  ||| S:841 E:852 ||| NNS
for  ||| S:852 E:856 ||| IN
detection  ||| S:856 E:866 ||| NN
and  ||| S:866 E:870 ||| CC
management  ||| S:870 E:881 ||| NN
of  ||| S:881 E:884 ||| IN
hyperbilirubinemia  ||| S:884 E:903 ||| JJ
underline  ||| S:903 E:913 ||| NN
how  ||| S:913 E:917 ||| WRB
prevention  ||| S:917 E:928 ||| NN
of  ||| S:928 E:931 ||| IN
badly  ||| S:931 E:937 ||| RB
managed  ||| S:937 E:945 ||| VBN
breastfeeding  ||| S:945 E:959 ||| NNS
and  ||| S:959 E:963 ||| CC
early  ||| S:963 E:969 ||| JJ
support  ||| S:969 E:977 ||| NN
for  ||| S:977 E:981 ||| IN
the  ||| S:981 E:985 ||| DT
couple  ||| S:985 E:992 ||| NN
mother-child  ||| S:992 E:1005 ||| NNS
are  ||| S:1005 E:1009 ||| VBP
effective  ||| S:1009 E:1019 ||| JJ
prevention  ||| S:1019 E:1030 ||| NN
measures  ||| S:1030 E:1039 ||| NNS
against  ||| S:1039 E:1047 ||| IN
severe  ||| S:1047 E:1054 ||| JJ
early-onset  ||| S:1054 E:1066 ||| JJ
jaundice ||| S:1066 E:1074 ||| NN
;  ||| S:1074 E:1076 ||| :
furthermore ||| S:1076 E:1087 ||| RB
,  ||| S:1087 E:1089 ||| ,
the  ||| S:1089 E:1093 ||| DT
breastfeeding  ||| S:1093 E:1107 ||| JJ
interruption  ||| S:1107 E:1120 ||| NN
is  ||| S:1120 E:1123 ||| VBZ
no  ||| S:1123 E:1126 ||| RB
longer  ||| S:1126 E:1133 ||| RB
recommended  ||| S:1133 E:1145 ||| VBN
as  ||| S:1145 E:1148 ||| IN
a  ||| S:1148 E:1150 ||| DT
diagnostic  ||| S:1150 E:1161 ||| JJ
procedure  ||| S:1161 E:1171 ||| NN
to  ||| S:1171 E:1174 ||| TO
identify  ||| S:1174 E:1183 ||| VB
breast  ||| S:1183 E:1190 ||| JJ
milk  ||| S:1190 E:1195 ||| NN
jaundice  ||| S:1195 E:1204 ||| NN
because  ||| S:1204 E:1212 ||| IN
of  ||| S:1212 E:1215 ||| IN
its  ||| S:1215 E:1219 ||| PRP$
low  ||| S:1219 E:1223 ||| JJ
specificity  ||| S:1223 E:1235 ||| NN
and  ||| S:1235 E:1239 ||| CC
the  ||| S:1239 E:1243 ||| DT
risk  ||| S:1243 E:1248 ||| NN
to  ||| S:1248 E:1251 ||| TO
disregarding  ||| S:1251 E:1264 ||| VB
the  ||| S:1264 E:1268 ||| DT
detection  ||| S:1268 E:1278 ||| NN
of  ||| S:1278 E:1281 ||| IN
a  ||| S:1281 E:1283 ||| DT
potentially  ||| S:1283 E:1295 ||| RB
dangerous  ||| S:1295 E:1305 ||| JJ
disease ||| S:1305 E:1312 ||| NN
.  ||| S:1312 E:1314 ||| .
